356 related articles for article (PubMed ID: 36232355)
1. Metabolic Reprogramming in Tumor Endothelial Cells.
García-Caballero M; Sokol L; Cuypers A; Carmeliet P
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232355
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between cancer cells and endothelial cells: implications for tumor progression and intervention.
Choi H; Moon A
Arch Pharm Res; 2018 Jul; 41(7):711-724. PubMed ID: 29961196
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming endothelial cells to empower cancer immunotherapy.
Cleveland AH; Fan Y
Trends Mol Med; 2024 Feb; 30(2):126-135. PubMed ID: 38040601
[TBL] [Abstract][Full Text] [Related]
4. Inducing vascular normalization: A promising strategy for immunotherapy.
Luo X; Zou W; Wei Z; Yu S; Zhao Y; Wu Y; Wang A; Lu Y
Int Immunopharmacol; 2022 Nov; 112():109167. PubMed ID: 36037653
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia control to normalize pathologic angiogenesis: potential role for endothelial precursor cells and miRNAs regulation.
Collet G; Skrzypek K; Grillon C; Matejuk A; El Hafni-Rahbi B; Lamerant-Fayel N; Kieda C
Vascul Pharmacol; 2012; 56(5-6):252-61. PubMed ID: 22446152
[TBL] [Abstract][Full Text] [Related]
6. Defining the role of the tumor vasculature in antitumor immunity and immunotherapy.
Schaaf MB; Garg AD; Agostinis P
Cell Death Dis; 2018 Jan; 9(2):115. PubMed ID: 29371595
[TBL] [Abstract][Full Text] [Related]
7. Tumor Vasculature as an Emerging Pharmacological Target to Promote Anti-Tumor Immunity.
Tzeng HT; Huang YJ
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901858
[TBL] [Abstract][Full Text] [Related]
8. Vessel pruning or healing: endothelial metabolism as a novel target?
Cantelmo AR; Pircher A; Kalucka J; Carmeliet P
Expert Opin Ther Targets; 2017 Mar; 21(3):239-247. PubMed ID: 28081641
[TBL] [Abstract][Full Text] [Related]
9. Endothelial Cells in the Tumor Microenvironment.
Sobierajska K; Ciszewski WM; Sacewicz-Hofman I; Niewiarowska J
Adv Exp Med Biol; 2020; 1234():71-86. PubMed ID: 32040856
[TBL] [Abstract][Full Text] [Related]
10. Altered angiogenesis in the tumor microenvironment.
Hida K; Kawamoto T; Ohga N; Akiyama K; Hida Y; Shindoh M
Pathol Int; 2011 Nov; 61(11):630-7. PubMed ID: 22029673
[TBL] [Abstract][Full Text] [Related]
11. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
[TBL] [Abstract][Full Text] [Related]
12. Endothelial Progenitors in the Tumor Microenvironment.
Testa U; Pelosi E; Castelli G
Adv Exp Med Biol; 2020; 1263():85-115. PubMed ID: 32588325
[TBL] [Abstract][Full Text] [Related]
13. The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer.
Missiaen R; Mazzone M; Bergers G
Semin Cancer Biol; 2018 Oct; 52(Pt 2):107-116. PubMed ID: 29935312
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapeutic Targeting of Tumor-Associated Blood Vessels.
Fabian KL; Storkus WJ
Adv Exp Med Biol; 2017; 1036():191-211. PubMed ID: 29275473
[TBL] [Abstract][Full Text] [Related]
15. Dual role of endothelial
Kabir AU; Subramanian M; Lee DH; Wang X; Krchma K; Wu J; Naismith T; Halabi CM; Kim JY; Pulous FE; Petrich BG; Kim S; Park HC; Hanson PI; Pan H; Wickline SA; Fremont DH; Park C; Choi K
Sci Transl Med; 2021 Mar; 13(583):. PubMed ID: 33658356
[TBL] [Abstract][Full Text] [Related]
16. Contribution of Tumor Endothelial Cells in Cancer Progression.
Hida K; Maishi N; Annan DA; Hida Y
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695087
[TBL] [Abstract][Full Text] [Related]
17. Tumor angiogenesis--characteristics of tumor endothelial cells.
Hida K; Maishi N; Torii C; Hida Y
Int J Clin Oncol; 2016 Apr; 21(2):206-212. PubMed ID: 26879652
[TBL] [Abstract][Full Text] [Related]
18. Vesicular trafficking mechanisms in endothelial cells as modulators of the tumor vasculature and targets of antiangiogenic therapies.
Maes H; Olmeda D; Soengas MS; Agostinis P
FEBS J; 2016 Jan; 283(1):25-38. PubMed ID: 26443003
[TBL] [Abstract][Full Text] [Related]
19. Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade.
Zheng W; Qian C; Tang Y; Yang C; Zhou Y; Shen P; Chen W; Yu S; Wei Z; Wang A; Lu Y; Zhao Y
Front Immunol; 2022; 13():1035323. PubMed ID: 36439137
[TBL] [Abstract][Full Text] [Related]
20. Engineering a Vascularized Hypoxic Tumor Model for Therapeutic Assessment.
Ando Y; Oh JM; Zhao W; Tran M; Shen K
Cells; 2021 Aug; 10(9):. PubMed ID: 34571851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
